Meanwhile, Tau in cerebrospinal fluid (CSF) and Apolipoprotein E ε4 (APOE 4) are all associated with increased risk of progression from MCI to dementia (Arnold et al., 2010) and they are the robust predictors of AD (Blom et al., 2009). Here, MAPT is linked to Alzheimer disease.